# Melvin George

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/melvin-george/

## Facts

| Field | Value |
| --- | --- |
| Citations | 1,626 |
| Field | Lipoproteins and Cardiovascular Health |
| h-index | 19 |
| i10-index | 36 |
| Last Known Institution | SRM Institute of Science and Technology |
| OpenAlex ID | https://openalex.org/A5031940496 |
| ORCID iD | 0000-0001-7101-8513 |
| Works | 151 |

## Researcher papers

- [Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial](https://scholariq.org/papers/efficacy-safety-and-lot-to-lot-immunogenicity-of-an-inactivated-sars-cov-2/)
- [A Type 1 Diabetes Genetic Risk Score Predicts Progression of Islet Autoimmunity and Development of Type 1 Diabetes in Individuals at Risk](https://scholariq.org/papers/a-type-1-diabetes-genetic-risk-score-predicts-progression-of-islet-autoimmunity/)
- [GDF 15 - A Novel Biomarker in the Offing for Heart Failure](https://scholariq.org/papers/gdf-15-a-novel-biomarker-in-the-offing-for-heart-failure/)
- [New and Emerging Drug Molecules Against Obesity](https://scholariq.org/papers/new-and-emerging-drug-molecules-against-obesity/)
- [TEVAR for complicated and uncomplicated type B aortic dissection—Systematic review and meta‐analysis](https://scholariq.org/papers/tevar-for-complicated-and-uncomplicated-type-b-aortic-dissection-systematic/)
- [Utility of galectin-3 as a prognostic biomarker in heart failure: where do we stand?](https://scholariq.org/papers/utility-of-galectin-3-as-a-prognostic-biomarker-in-heart-failure-where-do-we/)
- [Neuroprotective agents in Acute Ischemic Stroke—A Reality Check](https://scholariq.org/papers/neuroprotective-agents-in-acute-ischemic-stroke-a-reality-check/)
- [Value of pentraxin-3 and galectin-3 in acute coronary syndrome: a short-term prospective cohort study](https://scholariq.org/papers/value-of-pentraxin-3-and-galectin-3-in-acute-coronary-syndrome-a-short-term/)
- [A peek into the drug development scenario of endometriosis – A systematic review](https://scholariq.org/papers/a-peek-into-the-drug-development-scenario-of-endometriosis-a-systematic-review/)
- [Effect of tolvaptan on acute heart failure with hyponatremia – A randomized, double blind, controlled clinical trial](https://scholariq.org/papers/effect-of-tolvaptan-on-acute-heart-failure-with-hyponatremia-a-randomized-double/)
- [Advancing therapeutic approaches and shaping future perspectives in the management of autosomal dominant polycystic kidney disease (ADPKD): Insights from clinical trials](https://scholariq.org/papers/advancing-therapeutic-approaches-and-shaping-future-perspectives-in-the/)

## Researcher topics

- [Lipoproteins and Cardiovascular Health](https://scholariq.org/topics/lipoproteins-and-cardiovascular-health/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)
- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Biomarkers in Disease Mechanisms](https://scholariq.org/topics/biomarkers-in-disease-mechanisms/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Researcher university

- [SRM Institute of Science and Technology](https://scholariq.org/institutions/srm-institute-of-science-and-technology/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.